Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will participate in the 2026 Jefferies Global Healthcare Conference in New York, NY.
The company is scheduled for a fireside chat on Thursday, June 4, 2026, from 10:30–11:00 a.m. Eastern Time. A live webcast and 30-day replay will be available on its investor website.
Positive
- None.
Negative
- None.
News Market Reaction – NVAX
In the Jun 2 session, NVAX declined 2.85%, reflecting a moderate negative market reaction. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 07 | Conference participation | Neutral | +9.5% | Announcement of participation in BofA Securities 2026 Health Care Conference. |
| May 06 | Earnings release | Negative | +15.6% | Q1 2026 results with revenue down 79% year-over-year to $140M. |
| Apr 29 | Earnings date notice | Neutral | -0.6% | Scheduling announcement for Q1 2026 financial results and webcast details. |
| Mar 30 | Leadership change | Positive | -4.3% | Appointment of Dr. Robert Walker as EVP and Head of R&D. |
| Feb 26 | Conference participation | Neutral | -9.4% | Plan to attend multiple March 2026 investor conferences with webcasts. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows sizable price swings around both conference participation and fundamental updates, including strong positive reactions to the Q1 2026 earnings release despite sharply lower revenue, and mixed reactions to conference announcements.
Over the last few months, Novavax has mixed operational and investor-relations catalysts. A BofA 2026 conference participation headline on May 13, 2026 coincided with a 9.53% move. Q1 2026 earnings on May 6, 2026 reported revenue falling from $667M to $140M, yet the stock moved 15.56% higher. An R&D leadership change on Mar 30, 2026 and multiple March investor conferences produced negative or volatile reactions, underscoring that investor responses to news have been inconsistent.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Details: | |
Fireside Chat | |
Date: | Thursday, June 4, 2026 |
Time: | 10:30 – 11:00 a.m. Eastern Time |
Location: | |
Recordings
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-2026-jefferies-global-healthcare-conference-302787486.html
SOURCE Novavax, Inc.